BERGSTEIN IVAN (Chief Executive Officer) sold 2.0% of their position (57.45K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $286.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/13/2020ACC: 0001104659-20-033489
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-57.45K
Net shares
Net seller
$286.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
57.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20.91K
Price / share
$5.09
Trade value
$106.43K
% of position
0.7%
3/9/2020
2.92M→2.89M
Common Stock
Direct
Shares
−36.54K
Price / share
$4.92
Trade value
$179.79K
% of position
1.3%
3/10/2020
2.89M→2.86M
Total
Net shares
−57.45K
Net value
-$286.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2020 | S · Sale | −20.91K | $5.09 | $106.43K | 0.7% | 2.92M | 2.89M |
| Common Stock Direct | 3/10/2020 | S · Sale | −36.54K | $4.92 | $179.79K | 1.3% | 2.89M | 2.86M |
| Total | −57.45K | -$286.21K | ||||||
Derivative Transactions0
No derivative transactions reported